Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 17INDUSTRY 10UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 81Observational 10

Sponsor

Cancer Type

Breast 8Endocrine 1

Conditions

Breast Neoplasms 7Patient Compliance 2Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 1Arthralgia 1Advanced Breast Cancer 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

10 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Anastrozole × Clear all
NCT06930859 2026-05-22

ELEGANCE

Novartis

Recruiting
2,766 enrolled
Breast

Breast Neoplasms

NCT06905301 2026-05-05

IMPULSE

Novartis

Recruiting
240 enrolled
Breast

Breast Neoplasms

NCT06495164 2025-11-25

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Pfizer

Active not recruiting
1 enrolled
Breast

Breast Neoplasms

NCT06086340 2025-11-18

Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

Pfizer

Completed
779 enrolled 9 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02753686 2023-02-15

Treat ER+ight

Novartis

Completed
440 enrolled
Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT00562458 2013-02-05

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

AstraZeneca

Completed
200 enrolled
Breast

Advanced Breast Cancer

NCT00660244 2012-06-06

Breast Cancer Tumor Care Observational Programme

AstraZeneca

Completed
150 enrolled

Arthralgia

NCT00936442 2012-02-14

ARTEMIS

AstraZeneca

Completed
104 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00555867 2011-12-23

PACT

AstraZeneca

Terminated
4,923 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00638391 2008-03-20

Ax-003

AstraZeneca

Completed
1,600 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡